Cardiovascular Disease Early Detection and Prevention Act of 2026
The Cardiovascular Disease Early Detection and Prevention Act of 2026 mandates that private health insurance plans, Medicare, and Medicaid cover specific cardiovascular disease screenings. The bill requires coverage for testing of lipoprotein(a) (Lp(a)) and apolipoprotein B (ApoB) levels. This coverage applies to individuals with a family history of premature cardiovascular disease, a personal history of heart attack or stroke, elevated LDL cholesterol, diabetes, obesity, or other recognized cardiovascular risk factors. For eligible individuals, these tests must be provided without any cost sharing, such as co-pays or deductibles.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2026
Committee Review
Floor Vote
President
Introduced Apr 14, 2026
Last action Apr 14, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 14, 2026
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 14, 2026
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Sheila Cherfilus-McCormick
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8260
Scope: US
Hi! I can help you understand HR 8260. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline